Emerging studies suggest this peptide, a dual activator targeting both GLP-1 and GIP , could provide a significant step forward for weight loss . Early patient investigations have indicated substantial decreases in visceral fat , potentially surpassing existing body composition therapies . Nevertheless , more assessment is required to thoroughly as